JP2022553703A5 - - Google Patents
Info
- Publication number
- JP2022553703A5 JP2022553703A5 JP2022523575A JP2022523575A JP2022553703A5 JP 2022553703 A5 JP2022553703 A5 JP 2022553703A5 JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022553703 A5 JP2022553703 A5 JP 2022553703A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- isolated antibody
- approximately
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926914P | 2019-10-28 | 2019-10-28 | |
| US62/926,914 | 2019-10-28 | ||
| US202063094170P | 2020-10-20 | 2020-10-20 | |
| US63/094,170 | 2020-10-20 | ||
| PCT/US2020/057635 WO2021086899A1 (en) | 2019-10-28 | 2020-10-28 | Anti-hemagglutinin antibodies and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553703A JP2022553703A (ja) | 2022-12-26 |
| JP2022553703A5 true JP2022553703A5 (cg-RX-API-DMAC7.html) | 2023-09-26 |
| JP7611908B2 JP7611908B2 (ja) | 2025-01-10 |
Family
ID=73498317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523575A Active JP7611908B2 (ja) | 2019-10-28 | 2020-10-28 | 抗血球凝集素抗体およびその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11773156B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4051707A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7611908B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220088446A (cg-RX-API-DMAC7.html) |
| CN (2) | CN114761428B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020374878B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022007923A2 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2022001067A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2022005281A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL292353A (cg-RX-API-DMAC7.html) |
| MY (1) | MY207220A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12022550963A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021086899A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4508077A4 (en) | 2022-04-14 | 2026-03-25 | Invisishield Tech Ltd | COMPOSITIONS FOR PREVENTING OR TREATMENT OF INFLUENZA INFECTIONS |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| EP1740946B1 (en) | 2004-04-20 | 2013-11-06 | Genmab A/S | Human monoclonal antibodies against cd20 |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| ATE537190T1 (de) | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| TWI507525B (zh) | 2009-06-26 | 2015-11-11 | Regeneron Pharma | 具天然免疫球蛋白形式之易分離的雙專一性抗體 |
| SG183149A1 (en) | 2010-02-08 | 2012-09-27 | Regeneron Pharma | Common light chain mouse |
| JP6170507B2 (ja) * | 2012-01-31 | 2017-07-26 | 国立大学法人大阪大学 | B型インフルエンザウイルスに対する広範な保護を与えるヒトモノクローナル抗体及びその使用方法 |
| HUE037659T2 (hu) * | 2012-03-16 | 2018-09-28 | Regeneron Pharma | Hisztidinmódosított könnyûlánc antitestek és genetikailag módosított rágcsálók ennek az elõállítására |
| TWI682941B (zh) | 2013-02-01 | 2020-01-21 | 美商再生元醫藥公司 | 含嵌合恆定區之抗體 |
| US10639370B2 (en) | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| AU2015214146B2 (en) * | 2014-02-04 | 2020-09-17 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| MX2016012530A (es) * | 2014-03-27 | 2017-01-05 | Genentech Inc | Anticuerpos de hemaglutinina contra el virus de la influenza b y metodos de uso. |
| WO2016011035A2 (en) * | 2014-07-15 | 2016-01-21 | Medlmmune, Llc | Neutralizing anti-influenza b antibodies and uses thereof |
| TWI701258B (zh) * | 2014-12-19 | 2020-08-11 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| MX389708B (es) * | 2015-06-01 | 2025-03-20 | Medimmune Llc | Neutralizacion de moleculas de union anti-influenza y usos de las mismas. |
| AU2016270147B2 (en) | 2015-06-03 | 2018-08-23 | Xiamen University | Broad-spectrum monoclonal anti-flu B antibody and uses thereof |
| EP3471767A4 (en) * | 2016-06-15 | 2020-01-15 | Icahn School of Medicine at Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| WO2018187706A2 (en) * | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
| SG11202006379UA (en) * | 2018-01-26 | 2020-07-29 | Regeneron Pharma | Human antibodies to influenza hemagglutinin |
-
2020
- 2020-10-28 JP JP2022523575A patent/JP7611908B2/ja active Active
- 2020-10-28 WO PCT/US2020/057635 patent/WO2021086899A1/en not_active Ceased
- 2020-10-28 AU AU2020374878A patent/AU2020374878B2/en active Active
- 2020-10-28 CN CN202080084529.XA patent/CN114761428B/zh active Active
- 2020-10-28 IL IL292353A patent/IL292353A/en unknown
- 2020-10-28 EP EP20811191.4A patent/EP4051707A1/en active Pending
- 2020-10-28 BR BR112022007923A patent/BR112022007923A2/pt unknown
- 2020-10-28 MY MYPI2022002059A patent/MY207220A/en unknown
- 2020-10-28 KR KR1020227016672A patent/KR20220088446A/ko active Pending
- 2020-10-28 CN CN202610591737.8A patent/CN122521584A/zh active Pending
- 2020-10-28 US US17/082,375 patent/US11773156B2/en active Active
- 2020-10-28 PH PH1/2022/550963A patent/PH12022550963A1/en unknown
-
2022
- 2022-04-27 CO CONC2022/0005281A patent/CO2022005281A2/es unknown
- 2022-04-27 CL CL2022001067A patent/CL2022001067A1/es unknown
-
2023
- 2023-08-21 US US18/453,207 patent/US20240083983A1/en active Pending
-
2025
- 2025-11-21 AU AU2025271140A patent/AU2025271140A1/en active Pending